Corcept Therapeutics Incorporated
News
Do Options Traders Know Something About Corcept (CORT) Stock We Don't?
Zacks Investment Research Investors in Corcept Therapeutics Incorporated CORT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $12.00 Put had some of the...\n more…
Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?
Zacks Investment Research A month has gone by since the last earnings report for Catalyst Pharmaceutical (CPRX). Shares have added about 8.3% in that time frame, outperforming the S&P 500.Will the recent positive trend...\n more…
If EPS Growth Is Important To You, Corcept Therapeutics (NASDAQ:CORT) Presents An Opportunity
Simply Wall St The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...\n more…
Zurcher Kantonalbank Zurich Cantonalbank Lowers Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)
Zolmax Zurcher Kantonalbank Zurich Cantonalbank lowered its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 20.7% in the 2nd quarter, according to its most recent 13F filing...\n more…
Bank of New York Mellon Corp Has $22.03 Million Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)
Zolmax Bank of New York Mellon Corp lessened its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 6.3% during the second quarter, according to its most recent 13F filing with...\n more…
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Purchased by nVerses Capital LLC
Ticker Report nVerses Capital LLC raised its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 62.5% in the 2nd quarter, Holdings Channel reports. The fund owned 3,900 shares of the...\n more…